首页 › 基金 › Revelation Capital Management, LLC › ARTV
Revelation Capital Management, LLC 对 ARTV 的持仓历史
ARTIVA BIOTHERAPEUTICS INC · 医疗保健
Revelation Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 ARTV(ARTIVA BIOTHERAPEUTICS INC)299,311 股,市值约 US$2.1M,约占其申报组合的 26.60%,在其申报持仓中市值排名第 2 位。 Revelation Capital Management, LLC 最近 4 个申报季度中有 4 个季度披露了 ARTV 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-03 · 来源: SEC EDGAR Form 13F-HR
Revelation Capital Management, LLC 对 ARTV 的持仓演变
Revelation Capital Management, LLC 于 Q4 2025 首次披露 ARTV 持仓:299,311 股(约 US$1.3M)。 该持仓在 Q2 2026 达到峰值 299,311 股,市值约 US$2.9M。 在 4 次申报中,Revelation Capital Management, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 299,311 股、市值约 US$2.1M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 299.31K | $1.28M | 新进 |
| Q1 2026 | 299.31K | $1.93M | 持有 |
| Q2 2026 | 299.31K | $2.90M | 持有 |
| Q3 2026 | 299.31K | $2.13M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ARTV 与 13F 数据
ARTV(ARTIVA BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 ARTV,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARTV 的基金
- RA CAPITAL MANAGEMENT, L.P. 17.96M 股 · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M 股 · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M 股 · $19.82M · Q2 2026
- Caligan Partners LP 1.74M 股 · $16.84M · Q2 2026
- Samsara BioCapital, LLC 954.86K 股 · $9.26M · Q2 2026
- Blue Owl Capital Holdings LP 874.54K 股 · $8.48M · Q2 2026
- Propel Bio Management, LLC 696.44K 股 · $6.76M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K 股 · $5.09M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K 股 · $2.53M · Q2 2026
- KVP Capital Advisors, LP 200.00K 股 · $1.94M · Q2 2026
- Velan Capital Investment Management LP 25.00K 股 · $242.50K · Q2 2026
- Spark Investment Management LLC 16.50K 股 · $160.05K · Q2 2026
更多关于 Revelation Capital Management, LLC
常见问题
How long has Revelation Capital Management, LLC held ARTV?
Revelation Capital Management, LLC has disclosed ARTV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Revelation Capital Management, LLC's current position in ARTV?
As of Q3 2026, Revelation Capital Management, LLC holds 299.31K shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $2.13M, representing 26.60% of its reported portfolio and ranking #2.
Has Revelation Capital Management, LLC been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Revelation Capital Management, LLC held unchanged its position in ARTV. The position peaked in Q2 2026 at 299.31K shares.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.